E
Aquarius Surgical Technologies Inc. AQQRF
$0.0042 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 12/2/2024Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E- from E+ on 12/2/2024 due to a large decline in the solvency index. The quick ratio declined from 0.07 to 0.03, and debt to equity increased from -0.86 to -0.83.
E
Sell 5/10/2023Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E+ from D- on 5/10/2023 due to a noticeable decline in the total return index and volatility index.
D
Sell 4/25/2023Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D- from E+ on 4/25/2023 due to a substantial increase in the valuation index and volatility index.
E
Sell 4/10/2023Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E+ from D- on 4/10/2023 due to a decline in the volatility index.
D
Sell 3/14/2023Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell 3/7/2023Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D from D+ on 3/7/2023 due to a noticeable decline in the growth index, volatility index and solvency index. Operating cash flow declined 143.06% from $160.7 to -$69.2, earnings per share declined from -$0.0054 to -$0.0078, and EBIT declined 38.27% from -$105.3 to -$145.6.
D
Sell 2/17/2023Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D+ from D- on 2/17/2023 due to an increase in the volatility index.
D
Sell 2/8/2023Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index and valuation index. Total revenue declined 78% from $81.8 to $18.
D
Sell 6/21/2022Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 6/21/2022 due to an increase in the volatility index.
D
Sell 6/3/2022Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 6/3/2022 due to a decline in the volatility index.
D
Sell 5/16/2022Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from E+ on 05/16/2022.
E
Sell 5/13/2022Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell 5/4/2022Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell 5/1/2022Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E+ from D on 05/01/2022.
D
Sell 4/21/2022Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from E+ on 04/21/2022.
E
Sell 4/20/2022Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the valuation index and growth index. Total revenue declined 60.59% from $115.7 to $45.6, EBIT declined 5% from -$112 to -$117.6, and earnings per share declined from -$0.0065 to -$0.0068.
D
Sell 11/24/2021Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 11/24/2021 due to a significant increase in the growth index and volatility index. Total revenue increased 182.89% from $40.9 to $115.7, EBIT increased 28.8% from -$157.3 to -$112, and earnings per share increased from -$0.0086 to -$0.0065.
D
Sell 11/23/2021Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D- from E+ on 11/23/2021.
E
Sell 11/8/2021Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E+ from D- on 11/8/2021 due to a decline in the total return index, volatility index and solvency index.
D
Sell 9/24/2021Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 9/24/2021 due to a major decline in the growth index, solvency index and volatility index. EBIT declined 348.15% from -$35.1 to -$157.3, operating cash flow declined 127.34% from $75.7 to -$20.7, and total revenue declined 84.13% from $257.7 to $40.9.
D
Sell 3/3/2021Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 3/3/2021 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 70.23% from -$66.5 to -$19.8, EBIT increased 22.08% from -$205.6 to -$160.2, and earnings per share increased from -$0.0118 to -$0.0093.
D
Sell 2/19/2021Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 2/19/2021 due to a decline in the volatility index, total return index and valuation index.
D
Sell 1/29/2021Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 1/29/2021 due to an increase in the volatility index.
D
Sell 1/13/2021Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 1/13/2021 due to a large decline in the total return index, growth index and volatility index. Total revenue declined 10.9% from $67 to $59.7, EBIT declined 7.25% from -$191.7 to -$205.6, and earnings per share declined from -$0.0112 to -$0.012.
D
Sell 5/1/2020Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index, total return index and valuation index. Operating cash flow increased 21.22% from -$348.8 to -$274.8.
D
Sell 2/10/2020Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 2/10/2020 due to a decline in the volatility index, total return index and growth index.
D
Sell 11/25/2019Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 11/25/2019 due to an increase in the total return index, efficiency index and volatility index.
D
Sell 8/27/2019Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 8/27/2019 due to a decline in the efficiency index and valuation index.
D
Sell 6/13/2019Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 6/13/2019 due to an increase in the total return index and volatility index.
D
Sell 3/29/2019Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to D- from D on 3/29/2019 due to a decline in the volatility index, total return index and solvency index. Debt to equity increased from -23.13 to -6.1.
D
Sell 10/1/2018Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D from D- on 10/1/2018 due to an increase in the efficiency index, growth index and volatility index. Earnings per share increased from -$0.2091 to -$0.0155, net income increased 92.34% from -$3.83M to -$293.3, and EBIT increased 28.56% from -$407.9 to -$291.4.
D
Sell 6/5/2018Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to D- from E on 6/5/2018 due to an increase in the volatility index and total return index.
E
Sell 5/25/2018Downgrade
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E from E+ on 5/25/2018 due to a decline in the volatility index, solvency index and total return index.
E
Sell 3/1/2018Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to E+ from E on 3/1/2018 due to an increase in the total return index, solvency index and volatility index.
E
Sell 1/19/2018Upgraded
Aquarius Surgical Technologies Inc. (AQQRF) was upgraded to E from E- on 1/19/2018 due to a noticeable increase in the volatility index, solvency index and total return index.
E
Sell 12/1/2017None
Aquarius Surgical Technologies Inc. (AQQRF) was downgraded to E- from U on 12/01/2017.
Weiss Ratings